New liposomal painkiller could improve knee surgery recovery
NCT ID NCT07366905
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a long-acting form of the painkiller bupivacaine (liposomal bupivacaine) for nerve blocks in the thigh during knee surgery. Researchers aimed to find the best dose to numb sensation and block movement. 79 adults having knee surgery took part, and the results will help guide future pain management.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- liposomal bupivacaine
- What this could lead to
- If successful, this could help doctors use the right dose of liposomal bupivacaine for better pain control during knee surgery.
- What could go wrong
- This is a small, early-phase study focused on finding the right dose, not on proving effectiveness. Results may not apply to all patients or surgeries.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KNEE ARTHROSCOPIC SURGERY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Anesthesiology,the Second Affiliated Hospital of Hainan Medical University
Haikou, Hainan, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.